Co-Authors
This is a "connection" page, showing publications co-authored by Charles Quesenberry and Jennifer Lam.
Connection Strength
0.493
-
Cancer in People with and without Hepatitis C Virus Infection: Comparison of Risk Before and After Introduction of Direct-Acting Antivirals. Cancer Epidemiol Biomarkers Prev. 2021 Dec; 30(12):2188-2196.
Score: 0.200
-
Hepatitis C treatment uptake and response among human immunodeficiency virus/hepatitis C virus-coinfected patients in a large integrated healthcare system. Int J STD AIDS. 2019 06; 30(7):689-695.
Score: 0.169
-
Life Expectancy of Insured People With and Without Hepatitis C Virus Infection, 2007-2017. Open Forum Infect Dis. 2020 Feb; 7(2):ofaa044.
Score: 0.045
-
Disparities in Initiation of Direct-Acting Antiviral Agents for Hepatitis C Virus Infection in an Insured Population. Public Health Rep. 2018 Jul/Aug; 133(4):452-460.
Score: 0.040
-
No Difference in Effectiveness of 8 vs 12 Weeks of Ledipasvir and Sofosbuvir for Treatment of Hepatitis C in Black Patients. Clin Gastroenterol Hepatol. 2018 Jun; 16(6):927-935.
Score: 0.039